Alnylam Pharma (ALNY), and BridgeBio Pharma (BBIO), which market drugs for a rare heart condition known as ATTR-CM, are on ...

Could this be the secret to Pfizer's rebound strategy?

Pfizer’s CEO, Albert Bourla, Ph.D., has yet to top the $33 million in compensation that he earned on the coattails of megablockbuster COVID-19 sales in 2022, but a $27.6 million pay package after a ...

The sizable yield comes with a concerning footnote. Just look at the rest of the story.

A 7% dividend yield will grab your attention, but be sure to read the fine print.

Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday. President Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks ...

A recent study pinpoints the two leading GLP-1 manufacturers as the top pharma companies cited the most across leading AI ...

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk ...